Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Paediatric Neurology Update 2014
Gina O’Grady
Neurology Fellow
Infantile spasms
Infantile onset epilepsy
~ 1 in 2250 infants
Onset usually 3-8 months
Manifestations
Brief symmetrical contractions of
musculature of the neck, trunk (axial)
and extremities lasting up to 5s
Commonly occur in clusters
Flexor/extensor or mixed
http://www.youtube.com/watch?v=kqp9LGlULxI
http://www.youtube.com/watch?v=aVoJtslvqOU
http://www.youtube.com/watch?v=hK3vkHcSb6Y
http://www.youtube.com/watch?v=HC4p7eTez1w
Manifestations
Developmental regression
Particularly if diagnosis is delayed
70-85% have delayed development
prior to the onset of spasms
Early recognition is crucial
Low threshold of suspicion
Repetitive/clustered events are a clue
Video is always helpful
Referral for urgent EEG/assessment
EEG Hypsarrhythmia – chaotic, disorganised, high
amplitude spike and slow wave activity
West syndrome
Epileptic spasms
Neurodevelopmental regression
EEG finding of hypsarrhythmia
When all three are present the eponym “West syndrome” is sometimes used
Named after English physician William
West, who published in The Lancet in 1841
describing his own son
Aetiology
“Symptomatic” - 60-70%
Have an underlying disorder identified
“Cryptogenic” - 10-40%
No underlying cause identified
May have a better prognosis
Aetiology
Structural Hypoxic ischaemic encephalopathy
Perinatal stroke
Periventricular leukomalacia
Periventricular haemorrhage
Malformation – brain malformation or focal cortical dysplasia
Genetic Neurocutaneous syndromes e.g. Tuberous
sclerosis, NF1, Sturge-Weber
Chromosomal anomalies – Down syndrome
ARX, CDKL5, FOXG1, GRIN1, GRIN2A, STXBP1
Aetiology
Metabolic
Phenyketonuria
Non-ketotic hyperglycinaemia
Leigh disease
Pyridoxine responsive epilepsy
Biotinidase deficiency
Infection
Congenital infection especially CMV
Tuberous sclerosis
7% of infants in the UK Infantile Spasms
Study
Tuberous sclerosis
Pellock et al. Infantile spasms: A U.S. consensus
report. Epilepsia. 2010 Jul 1;51(10):2175–89.
Investigations
EEG
MRI
Metabolic work up Urine metabolic screen, newborn screen,
vitamin B12, biotinidase, urine P6C, lactate, ammonia, CSF studies (lactate, protein, glucose, NTs, amino acids), serum amino acids, transferrin isoforms
CGH array
Congenital infection screen.
Ophthalmology review
Steroid therapy
UKISS - United Kingdom Infantile Spasm Study 10mg prednisolone QID – 2 weeks ○ If spasms continue on Day 7 or reappear
between Day 8 and Day 14 inclusive, increase the dose to 20 mg three times a day for the remaining doses
Followed by a tapering course
Prednisolone vs ACTH
UKISS United Kingdom Infantile Spasm Study
150 hospitals ; 107 infants with IS (excluding TSC)
Prednisolone or ACTH depot (n=55) vs vigabatrin (n=52)
Primary outcome – cessation of spasms by day 13 and 14:
Better initial control of spasms in infants allocated
hormonal treatment than in those allocated vigabatrin,
regardless of etiology (Lux 2004).
40/55 (73%) of infants assigned hormonal treatments
[prednisolone 21/30 [70%], tetracosactide 19/25 [76%]] vs
28 (54%) of 52 infants assigned vigabatrin
UKISS United Kingdom Infantile Spasm Study
14mo and 4 year (n=77) follow up
Nine of 107 infants had died.
Longer lead time to treatment associated with worse
neurodevelomental outcome
In the subgroup of infants with no identified aetiology,
development remained better in those allocated
hormonal treatment
Alternatives to steroids
Infants with Tuberous sclerosis – Vigabatrin
Nitrazepam
Ketogenic diet
Monitoring
Surveillance for steroid side effects
EEG surveillance
Monitoring for spasm/seizure
recurrence
Spasm relapse
Steroids
Vigabatrin
Nitrazepam
Topiramate
Vigabatrin
Risk of visual field constriction and
retinal toxicity ○ 1/3rd of children aged 9-19 years
○ Lower risk with short-term use
Abnormal MRI signal intensity in the
thalamus, basal ganglia, dentate
nucleus and brainstem – reversible
Pyridoxine
The possibility of pyridoxine dependent seizures should be considered although IS are not typical
Consider in those infants: with additional seizure types, and
where no other cause for their spasms is known.
Outcome
Abnormal development in >85%
Mental retardation
Autistic spectrum disorder
Refractory epilepsy
Other seizure types – >60%
Lennox-Gastaut syndrome – 40%
Neurodevelopmental follow up
Early treatment is associated with a better
neurodevelopmental outcome
UKISS – longer lead time to treatment
associated with a worse
neurodevelopmental outcome at 4
years.
Erroneous diagnoses
Gastroesophageal reflux
Constipation
Colitis
Differential diagnoses
Benign Infantile Shuddering http://www.youtube.com/watch?v=3kFcWh3yfKo
http://www.youtube.com/watch?v=fuuysAn5QDc&list=PLA3DB0838DC651F57&index=5
Benign sleep myoclonus
Conclusion
Early diagnosis
Low index of suspicion
Urgent referral
Early commencement of therapy
References
Go CY et al. Evidence-based guideline update: Medical
treatment of infantile spasms: Report of the Guideline
Development Subcommittee of the American Academy of
Neurology and the Practice Committee of the Child
Neurology Society. Neurology. 2012 Jun 11;78(24):1974–80.
Lux AL et al. The United Kingdom Infantile Spasms Study
comparing vigabatrin with prednisolone or tetracosactide at
14 days: a multicentre, randomised controlled trial. Lancet.
2004 Nov;364(9447):1773–8.
Pellock JM et al. Infantile spasms: A U.S. consensus report.
Epilepsia. 2010 Jul 1;51(10):2175–89.